SCHEMBL3233015

SCHEMBL3233015

COc1ccc(Nc2cc(C(=O)Nc3ccc(F)cc3)ncn2)cc1

nearest known ligand 0.58

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MEN1 O00255 5/20 0.58
KMT2A Q03164 5/20 0.58
EGFR P00533 3/20 0.58
ERBB3 P21860 3/20 0.58
ABL1 P00519 3/20 0.55
BCR P11274 3/20 0.55
NPC1 O15118 4/20 0.53
RAB9A P51151 4/20 0.53
SMN1; SMN2 Q16637 3/20 0.53
MAPT P10636 2/20 0.53
LMNA P02545 2/20 0.53
PKM P14618 1/20 0.51
S1PR1 P21453 1/20 0.50
KCNH2 Q12809 1/20 0.50
KDM4E B2RXH2 1/20 0.50
GAA P10253 1/20 0.50
USP2 O75604 1/20 0.48
ALDH1A1 P00352 1/20 0.48
CYP1A2 P05177 1/20 0.48
CYP2D6 P10635 1/20 0.48

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3222813 0.90 EGFR (0.64) MEN1KMT2AEGFRERBB3NPC1
SCHEMBL3222685 0.89 S1PR1 (0.63) MEN1KMT2AEGFRERBB3NPC1
SCHEMBL3225967 0.86 EGFR (0.57) EGFRERBB3NPC1RAB9ASMN1; SMN2
SCHEMBL3229185 0.86 EGFR (0.57) MEN1KMT2AEGFRERBB3NPC1
SCHEMBL3233497 0.86 KMT2A (0.51) MEN1KMT2AEGFRERBB3NPC1
SCHEMBL3228067 0.85 EGFR (0.58) MEN1KMT2AEGFRERBB3NPC1
SCHEMBL3221284 0.85 S1PR1 (0.63) EGFRERBB3NPC1RAB9ASMN1; SMN2
SCHEMBL3222525 0.85 EGFR (0.73) MEN1KMT2AEGFRERBB3NPC1
SCHEMBL13456856 0.84 EGFR (0.57) MEN1KMT2AEGFRERBB3NPC1
SCHEMBL3218204 0.83 EGFR (0.63) MEN1KMT2AEGFRERBB3ABL1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2010020432-A8 COMPOUNDS FOR TREATMENT OF DUCHENNE MUSCULAR DYSTROPHY BIOMARIN IGA LIMITED (BS) 2010-03-11 WO claimed
WO-2010020432-A2 COMPOUNDS FOR TREATMENT OF DUCHENNE MUSCULAR DYSTROPHY SUMMIT CORPORATION PLC (GB) 2010-02-25 WO claimed
WO-2010020432-A8 COMPOUNDS FOR TREATMENT OF DUCHENNE MUSCULAR DYSTROPHY BIOMARIN IGA LIMITED (BS) 2010-03-11 WO disclosed
WO-2010020432-A8 COMPOUNDS FOR TREATMENT OF DUCHENNE MUSCULAR DYSTROPHY BIOMARIN IGA LIMITED (BS) 2010-03-11 WO disclosed
WO-2010020432-A2 COMPOUNDS FOR TREATMENT OF DUCHENNE MUSCULAR DYSTROPHY SUMMIT CORPORATION PLC (GB) 2010-02-25 WO disclosed
WO-2010020432-A2 COMPOUNDS FOR TREATMENT OF DUCHENNE MUSCULAR DYSTROPHY SUMMIT CORPORATION PLC (GB) 2010-02-25 WO disclosed